Sorafenib‐ or 90Y‐loaded resin microsphere radioembolization for locally advanced hepatocellular carcinoma, what should we trust?

Publisher： John Wiley & Sons Inc

E-ISSN： 1478-3231|35|6|1779-1780

ISSN： 1478-3223

Source： LIVER INTERNATIONAL (ELECTRONIC), Vol.35, Iss.6, 2015-06, pp. : 1779-1780

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Reply to: “Sorafenib or 90Y loaded resin microsphere radioembolization for locally‐advanced hepatocellular carcinoma, what should we trust?”

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 35, Iss. 6, 2015-06 ,pp. : 1780-1781

John Wiley & Sons Inc

Access to resources Recommend Favorite

Yttrium‐90 radioembolization vs sorafenib for intermediate‐locally advanced hepatocellular carcinoma: a cohort study with propensity score analysis

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 35, Iss. 3, 2015-03 ,pp. : 1036-1047

John Wiley & Sons Inc

Access to resources Recommend Favorite

Yttrium-90 Radioembolization for Hepatocellular Carcinoma: What We Know and What We Need to Know

By  

Oncology, Vol. 84, Iss. 1, 2013-02 ,pp. : 34-39

Karger

Access to resources Recommend Favorite

Education and Imaging

By  

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol. 30, Iss. 3, 2015-03 ,pp. : 438-438

John Wiley & Sons Inc

Access to resources Recommend Favorite

Safety and toxicity of radioembolization plus Sorafenib in advanced hepatocellular carcinoma: analysis of the European multicentre trial SORAMIC

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 35, Iss. 2, 2015-02 ,pp. : 620-626

John Wiley & Sons Inc

Access to resources Recommend Favorite